Author:
Mohana Marimuthu,Muthiah Packianathan Thomas,McMillen Colin D.
Abstract
The design of a pharmaceutical cocrystal is based on the identification of specific hydrogen-bond donor and acceptor groups in active pharmaceutical ingredients (APIs) in order to choose a `complementary interacting' molecule that can act as an efficient coformer. 5-Fluorouracil (5FU) is a pyrimidine derivative with two N—H donors and C=O acceptors and shows a diversity of hydrogen-bonding motifs. Two 1:1 cocrystals of 5-fluorouracil (5FU), namely 5-fluorouracil–4-methylbenzoic acid (5FU–MBA), C4H3FN2O2·C8H8O2, (I), and 5-fluorouracil–3-nitrobenzoic acid (5FU–NBA), C4H3FN2O2·C7H5NO4, (II), have been prepared and characterized by single-crystal X-ray diffraction. In (I), the MBA molecules form carboxylic acid dimers [R
2
2(8) homosynthon]. Similarly, the 5FU molecules form two types of base pair via a pair of N—H...O hydrogen bonds [R
2
2(8) homosynthon]. In (II), 5FU interacts with the carboxylic acid group of NBA via N—H...O and O—H...O hydrogen bonds, generating an R
2
2(8) ring motif (heterosynthon). Furthermore, the 5FU molecules form base pairs [R
2
2(8) homosynthon] via N—H...O hydrogen bonds. Both of the crystal structures are stabilized by C—H...F interactions.
Publisher
International Union of Crystallography (IUCr)
Subject
Materials Chemistry,Inorganic Chemistry,Physical and Theoretical Chemistry,Condensed Matter Physics
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献